About Us
Research
Research
Latest Research News!
Background to research
Current Research
Previous Research Stories
Donating tissue for research
Donating tissue after death
Support
Giving & Events
Contact Us
Donate
Text Size
Contact Us
About Us
Our Background
Charity Origins
The Good Business Charter
Our Team
Join Team YBTC
Meet Our Team
Meet Our Patrons & Celebrity Ambassadors
Meet Our Ambassadors
Meet Our Volunteers
Beefy's Charity Foundation
Current Funds
Safeguarding
Research
Research
Latest Research News!
Background to research
Current Research
Previous Research Stories
Donating tissue for research
Donating tissue after death
Support
Support Services
Welfare Advice & Guidance
1-2-1 Peer Support
Peer Support Groups
Peer Support Walks
YBTC Support Line
Other Resources
Signs & Symptoms of a brain tumour
Managing anxiety before a scan
Travelling abroad after a diagnosis
Driving & transport after your diagnosis
Radiotherapy Masks
The Brain Tumour Patients' Charter of Rights
Giving & Events
Loving Fundraising
YBTC Events
Community Fundraising
Corporate Partnerships
Trusts & Foundations
Loving Shopping
YBTC Online Shop
Loving Giving
Donate Online
Other Ways To Donate
Payroll Giving
Regular Giving
Remember a loved one
Legacy Gifting
Contact Us
Research
Research
Latest Research News!
Team at University of Hull publishes new article
Team at University of Hull publishes new article
Led by Pedro Beltran-Alvarez, researchers at Hull have published new findings about possible side effects of a promising new drug.
Antonia Barry
, a YBTC-funded PhD student, is one of the authors of a new article published in
ACS Pharmacology & Translational Science
this August. To read the article in full,
CLICK HERE.
The team at the University of Hull, with the support of YBTC, are investigating a particular type of drug, called
arginine methylation inhibitors
, as emerging new therapies against brain tumours.
Arginine methylation inhibitors have recently begun to be investigated through clinical trials, some of which include brain tumour patients. Given that these inhibitors may soon be
approved for the treatment of cancer
, it is important to explore any side effects.
In this study, the authors found that arginine methylation inhibitors can
affect the function of platelets
, which are the cells in the blood that form clots and prevent bleeding when an injury occurs. This is important because current clinical trials will need to consider any adverse effects associated with bleeding when giving arginine methylation inhibitors to patients.
The authors recognise that therapies with arginine methylation inhibitors are very promising against a range of cancers. They continue to investigate these inhibitors, which show
great potential against brain tumours
. However, their research is the first to identify that
treatment will need to be monitored
for any excess bleeding, particularly in specific patients, such as those at risk of heart attacks or strokes who may be taking antiplatelet drugs (such as aspirin, clopidogrel, etc).
As such, this publication contributes greatly to the understanding of arginine methylation inhibitors and their potential in the treatment of brain tumours, and
could save lives
in current clinical trials.
The publication’s other authors were Alistair James Marsden, David R. J. Riley, Jawad S. Khalil, Barbara-ann Guinn, Neil T. Kemp, Francisco Rivero and Pedro Beltran-Alvarez.
Pedro-Beltran Alvarez is currently leading a research project using pioneering tissue-on-chip technology to discover diagnostic biomarkers of glioblastoma. To read more about this project,
CLICK HERE.
Antonia previously published her first paper back in January; a literature review focusing on arginine methylation inhibitors and their targets. To read more about this paper,
CLICK HERE.
Since 2003 you've helped us raise:
4,807,665.73
Helpful Links
Registered Charity No. 1095931
Contact Us
Office
Phone: 0113 340 0111
Email:
info@yorksbtc.org.uk
Support
Phone: 0113 511 8111
Email:
ybtcsupport@yorksbtc.org.uk
Find Us
Yorkshire's Brain Tumour Charity
31 Otley Road,
Headingley,
Leeds,
LS6 3AA
Yorkshire's Brain Tumour Charity, Registered Charity Address 31 Otley Road, Headingley, Leeds, LS6 3AA.
© Yorkshire's Brain Tumour Charity. Registered Charity No. 1095931
Privacy Policy
|
Cookie Policy
|
Refund Policy
|
Fundraising Promise
|
Complaints Policy
|
Covid-19
by pixelbuilders.com |
digital agency leeds
Make a Donation